Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Total raised: $50M
Investors 2
| Date | Name | Website |
| - | Apollo Ven... | apollo.vc |
| - | Sofinnova ... | sofinnova.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.03.2024 | - | $50M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 29.03.2024 | Aeovian Pharmaceuticals Closes $50M Financing | Aeovian Pharmaceuticals, a Berkeley, CA-based clinical-stage biopharmaceutical company, raised $50M ... | finsmes.co... |
| - | Aeovian Pharmaceuticals | “Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective th... | fastfounde... |